Anavex Life Sciences
AVXL
$3.57
Share price
3.77%
Change (1 day)
-56.14%
Change (1 year)
Categories
Anavex Life Sciences (AVXL) - P/B ratio
P/B ratio as of April 2024 : 2.08
According to Anavex Life Sciences
's latest financial reports the company has a price-to-book ratio of 2.08.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Anavex Life Sciences - P/B ratio (from 2006 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 5.64 | 5.51% |
| 2022-12-31 | 5.34 | -40.67% |
| 2021-12-31 | 9.01 | 15.31% |
| 2020-12-31 | 7.81 | 37.14% |
| 2019-12-31 | 5.69 | 34.07% |
| 2018-12-31 | 4.25 | -23.8% |
| 2017-12-31 | 5.57 | -31.85% |
| 2016-12-31 | 8.18 | -51.31% |
| 2015-12-31 | 16.8 | -21.62% |
| 2014-12-31 | 21.4 | -480.37% |
| 2013-12-31 | -5.63 | -21.5% |
| 2012-12-31 | -7.18 | -46.31% |
| 2011-12-31 | -13.4 | -98.64% |
| 2010-12-31 | -979 | 9617.35% |
| 2009-12-31 | -10.1 | -46% |
| 2008-12-31 | -18.7 | -93.37% |
| 2007-12-31 | -281 | -84.91% |
| 2006-12-31 | < -1000 | |
| 2005-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Ligand Pharmaceuticals LGND | 1.78 | -14.44% | 🇺🇸 USA |
 Corcept Therapeutics
CORT | 4.67 | 124.26% | 🇺🇸 USA |
 Palatin Technologies PTN | -2.58 | -223.82% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | -1.88 | -190.36% | 🇺🇸 USA |